A research position is available within a funded PRIN 2022 PNRR project entitled “A Chaperone Network Shapes Heart Resilience During Stress and Aging.” Join us to investigate the molecular mechanisms underlying chaperone protection in cardiac aging.
https://t.co/KF0j7I7jhn
DZHK Paper of the Month | Feb 2024 🥁🏆
From the 🫁 to the 🫀: Read about a novel peptide-based inhalation therapeutic for the treatment of #HeartFailure Congratulations to Alessio Alogna @dhzcharite & his team
https://t.co/ImfyjXJNUL
#CardioTwitter
Prosegue la sperimentazione dell'innovativa formulazione inalatoria per il trattamento delle malattie cardiache messa a punto nell’ambito del @cupido_project. I risultati sono descritti da uno studio coordinato da #Cnr_Irgb e @ChariteBerlin
👇
https://t.co/UFI9y34Yod
@MC_Carro
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances https://t.co/qzFms6Ll8A @GenScript
Discovering #NanoPhoria, a cutting-edge and brand-new startup developing a revolutionary and promising #HeartFailure inhalation treatment. Claudio De Luca, our CEO, explains how. Spoiler alert: it's done by a non-viral, biomimetic nanocarrier technology.
https://t.co/f2kUl9H2PN
NanoPhoria, società spin-off del #Cnr, ha ricevuto un investimento di 3,5milioni € da parte di @SofinnovaVC, una delle principali società europee di venture capital nel settore delle scienze della vita.
La società sarà presentata oggi a #Bioequity Milano
https://t.co/ufH5x18k5S
In its eighth disclosed investment from its Italy-focused Telethon fund, @SofinnovaVC has backed non-viral delivery company NanoPhoria with a €3.5M seed investment https://t.co/zqzlEwlfGL
We are pleased to welcome NanoPhoria to our portfolio via a €3.5 million seed investment that will advance its pre-clinical stage treatment for heart failure. #biotech
https://t.co/8qRL4Ayvfd
National Research Council (CNR) Institute of Genetic and Biomedical Research (IRGB) is #hiring a Research Position (either a junior or post- doctoral fellow)! #openposition https://t.co/vSSaVyODFC
at the TecMedLab @UNIPR in collaboration with @CNRsocial_ and @HumanitasMilano we growth SiC semiconductive nanowires to reinstate impulse propagation in 5 hrs after myocardial infarction. See our work published on @NatureComms.
https://t.co/mJ5Ixi3exJ
#ResearchLetter MicroRNA therapeutics in cardiology is limited by invasive administration. @DCatalucci et al. demonstrate a proof-of-concept inhalable nanoparticle microRNA delivery mechanism @CNRsocial_@HumanitasMilano https://t.co/kAHFnCpp5v
The Sheikh lab is recruiting postdocs to sunny #SanDiego with interest in molecular cardiology! Explore new methods to define therapeutic targets for cardiomyopathy--with focus on translation to industry! DM me! Please RT. #postdocjobs#phdjobs#academia#UCSD interested?@MrBeast
#Research Topic
The Role of Circulating Immune Mediators in the Crosstalk Between Cells of the Immune System and Cardiovascular Systems in CVDs @FrontImmunol https://t.co/cFVm6AMZ2U